AI Prospecting for AbbVie
Company data:
Company size:
50000 employeesWebsite URL:
https://www.abbvie.comIndustry
PharmaceuticalsHeadquarters:
North Chicago, Illinois, United StatesInvestment round:
Publicly Traded (NYSE: ABBV)ARR:
$56 billionKey stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about AbbVie
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
AbbVie raised its adjusted diluted EPS guidance for 2024 to $10.90 - $10.94 and completed the acquisition of Cerevel, adding assets like emraclidine for schizophrenia and tavapadon for Parkinson's disease. They also announced a definitive agreement to acquire Aliada Therapeutics, focusing on Alzheimer's disease treatments and novel blood-brain barrier-crossing technology[1].
AbbVie received European Commission approval for ELAHERE® (mirvetuximab soravtansine) for the treatment of platinum-resistant ovarian cancer[4]. AbbVie also announced a collaboration and option-to-license agreement with EvolveImmune Therapeutics to develop next-generation cancer biotherapeutics[5].
AbbVie announced a collaboration and option-to-license agreement with EvolveImmune Therapeutics to develop next-generation cancer biotherapeutics, and also declared a 5.8 percent increase in its quarterly dividend following strong commercial execution and pipeline progress[1][5].
Open job positions at AbbVie
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Manager, Franchise Commercial Systems
Business HR Manager
Associate Director, Advanced Analytics and Data Science
